Touyun Biotech Group Limited (1332.HK)

HKD 0.17

(0.0%)

Total Liabilities Summary of Touyun Biotech Group Limited

Touyun Biotech Group Limited's latest annual total liabilities in 2023 was 586.26 Million HKD , down -2.97% from previous year.
Touyun Biotech Group Limited's latest quarterly total liabilities in 2024 Q2 was 597.41 Million HKD , down 0.0% from previous quarter.
Touyun Biotech Group Limited reported annual total liabilities of 604.18 Million HKD in 2022, up 12.37% from previous year.
Touyun Biotech Group Limited reported annual total liabilities of 537.68 Million HKD in 2021, up 29.38% from previous year.
Touyun Biotech Group Limited reported quarterly total liabilities of 586.26 Million HKD for 2023 FY, down -2.97% from previous quarter.
Touyun Biotech Group Limited reported quarterly total liabilities of 549.12 Million HKD for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Touyun Biotech Group Limited (2023 - 2011)

Historical Annual Total Liabilities of Touyun Biotech Group Limited (2023 - 2011)

Year	Total Liabilities	Total Liabilities Growth
2023	586.26 Million HKD	-2.97%
2022	604.18 Million HKD	12.37%
2021	537.68 Million HKD	29.38%
2020	415.57 Million HKD	21.57%
2019	341.83 Million HKD	8.02%
2018	316.45 Million HKD	-18.97%
2017	390.54 Million HKD	431.11%
2016	73.53 Million HKD	-68.8%
2015	235.69 Million HKD	234.26%
2014	70.51 Million HKD	19.46%
2013	59.02 Million HKD	-4.54%
2012	61.82 Million HKD	-49.5%
2011	122.43 Million HKD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	597.41 Million HKD	0.0%
2023 FY	586.26 Million HKD	-2.97%
2023 Q2	549.12 Million HKD	0.0%
2023 Q4	586.26 Million HKD	0.0%
2022 Q2	588.24 Million HKD	0.0%
2022 Q4	604.18 Million HKD	0.0%
2022 FY	604.18 Million HKD	12.37%
2021 Q2	517.68 Million HKD	0.0%
2021 Q4	537.68 Million HKD	0.0%
2021 FY	537.68 Million HKD	29.38%
2020 Q2	293.18 Million HKD	0.0%
2020 Q4	415.57 Million HKD	0.0%
2020 FY	415.57 Million HKD	21.57%
2019 Q2	336.98 Million HKD	0.0%
2019 Q4	341.83 Million HKD	0.0%
2019 FY	341.83 Million HKD	8.02%
2018 Q4	316.45 Million HKD	0.0%
2018 FY	316.45 Million HKD	-18.97%
2018 Q2	405.32 Million HKD	0.0%
2017 Q4	390.54 Million HKD	0.0%
2017 Q2	109.8 Million HKD	0.0%
2017 FY	390.54 Million HKD	431.11%
2016 Q4	73.53 Million HKD	0.0%
2016 FY	73.53 Million HKD	-68.8%
2016 Q2	45.65 Million HKD	0.0%
2015 Q4	235.69 Million HKD	0.0%
2015 Q2	45.87 Million HKD	0.0%
2015 FY	235.69 Million HKD	234.26%
2014 Q4	70.51 Million HKD	0.0%
2014 FY	70.51 Million HKD	19.46%
2014 Q2	61.28 Million HKD	0.0%
2013 Q2	70.25 Million HKD	0.0%
2013 FY	59.02 Million HKD	-4.54%
2013 Q4	59.02 Million HKD	0.0%
2012 Q2	77.71 Million HKD	0.0%
2012 FY	61.82 Million HKD	-49.5%
2012 Q4	61.82 Million HKD	0.0%
2011 FY	122.43 Million HKD	0.0%
2011 Q4	122.43 Million HKD	0.0%

Peer Total Liabilities Comparison of Touyun Biotech Group Limited

Name	Total Liabilities	Total Liabilities Difference
Starlite Holdings Limited	266.35 Million HKD	-120.108%
Litu Holdings Limited	537.22 Million HKD	-9.13%
Champion Alliance International Holdings Limited	99.22 Million HKD	-490.828%
Huaxi Holdings Company Limited	173.29 Million HKD	-238.302%